Skip to Main Content

Author Details

Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
2001
78
34
PMIDPaper TitleJournal TitlePublished Year
35941803Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments.Hepatology2023
35941803Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments.Hepatology2023
37904980Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade.bioRxiv2023
37723590Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence.Genome Med2023
36712023Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence.bioRxiv2023
37080163Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces.Cell Syst2023
36812889Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma.Cell Rep Med2023
36914720Myo1e overexpression in lung adenocarcinoma is associated with increased risk of mortality.Sci Rep2023
37904980Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade.bioRxiv2023
37723590Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence.Genome Med2023
37080163Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces.Cell Syst2023
36812889Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma.Cell Rep Med2023
36914720Myo1e overexpression in lung adenocarcinoma is associated with increased risk of mortality.Sci Rep2023
36712023Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence.bioRxiv2023
35245816Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients.Mult Scler Relat Disord2022
36306792Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy.Cancer Cell2022
36214223Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trials.JCI Insight2022
36499607Novel Genes Involved in Hypertrophic Cardiomyopathy: Data of Transcriptome and Methylome Profiling.Int J Mol Sci2022
33666134DNA-methylation for the detection and distinction of 19 human malignancies.Epigenetics2022
35245816Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients.Mult Scler Relat Disord2022
36499607Novel Genes Involved in Hypertrophic Cardiomyopathy: Data of Transcriptome and Methylome Profiling.Int J Mol Sci2022
36214223Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trials.JCI Insight2022
36306792Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy.Cancer Cell2022
33666134DNA-methylation for the detection and distinction of 19 human malignancies.Epigenetics2022
34112666Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade.Science2021
33491650Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer.Elife2021
34283806Systemic inhibition of PTPN22 augments anticancer immunity.J Clin Invest2021
34112666Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade.Science2021
33985562Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways.Genome Biol2021
34796337Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity.Nat Cancer2021
34433588Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery.Cancer Immunol Res2021
34376232Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.Genome Med2021
33491650Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer.Elife2021
34433588Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery.Cancer Immunol Res2021
34376232Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.Genome Med2021
34796337Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity.Nat Cancer2021
33985562Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways.Genome Biol2021
34283806Systemic inhibition of PTPN22 augments anticancer immunity.J Clin Invest2021
31595832PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies.Epigenetics2020
31855578Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes.JCI Insight2020
31595832PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies.Epigenetics2020
32303615Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma.J Immunother Cancer2020
32401780Correction: Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma.PLoS One2020
31882448Revisiting the tumorigenesis timeline with a data-driven generative model.Proc Natl Acad Sci U S A2020
32164487Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma.Epigenetics2020
32213106Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy.Cancer Biol Ther2020
32273276Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer.Clin Cancer Res2020
33015029Extracellular Vesicles Released by Tumor Endothelial Cells Spread Immunosuppressive and Transforming Signals Through Various Recipient Cells.Front Cell Dev Biol2020
31855578Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes.JCI Insight2020
31882448Revisiting the tumorigenesis timeline with a data-driven generative model.Proc Natl Acad Sci U S A2020
  • 1 - 50 of 156

Recommended Authors

Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 2
Tao Wang
University of Texas Southwestern Medical Center
Career Start Year 2014
Number of shared co-authors 15
Laurie Tonon
Cancer Research Center of Lyon, UMR INSERM 2, CNRS 5286
Career Start Year 2010
Number of shared co-authors 5
Hyunchul Jung
Wellcome Sanger Institute
Career Start Year 2009
Number of shared co-authors 2
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 13
Riyue Bao
UPMC Hillman Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 3
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 26
Xiaotu Ma
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 4
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 3
Chao Cheng
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 4
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 30
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 13
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 7
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 14
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 19
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 62
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 3
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 13
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 76
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 13
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 11
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 18
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 1
Pablo Tamayo
University of California San Diego
Career Start Year 1988
Number of shared co-authors 40

Collaborators

Elana J Fertig
Johns Hopkins University School of Medicine
Co-authored papers 30
Alexander V Favorov
Johns Hopkins School of Medicine
Co-authored papers 17
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Co-authored papers 16
Daria A Gaykalova
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers 14
Leslie Cope
Johns Hopkins University School of Medicine
Co-authored papers 13
Joseph A Califano
University of California
Co-authored papers 11
Kenneth W Kinzler
Co-authored papers 9
Bert Vogelstein
Co-authored papers 9
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers 8
Michael J Considine
Johns Hopkins University School of Medicine
Co-authored papers 8
Nickolas Papadopoulos
Co-authored papers 7
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 6
Wayne M Koch
Johns Hopkins University School of Medicine
Co-authored papers 6
Genevieve L Stein-O'Brien
Johns Hopkins School of Medicine
Co-authored papers 6
Justin A Bishop
UT Southwestern Medical Center
Co-authored papers 6
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 5
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 5
Michael F Ochs
The College of New Jersey
Co-authored papers 5
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
William H Westra
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers 5
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 5
Victor E Velculescu
Co-authored papers 4
Tara M Lichtenberg
Co-authored papers 4
Zubair Khan
University of Texas at Houston Health Science Center
Co-authored papers 4
Roel G W Verhaak
Yale School of Medicine
Co-authored papers 4
Ina Felau
National Cancer Institute
Co-authored papers 3
Tobias Else
Harvard Medical School
Co-authored papers 3
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
Joel C Sunshine
Co-authored papers 3
Matthew Meyerson
Broad Institute
Co-authored papers 3
Release 1.2